Antimicrobial Peptides Discovery, Design and Novel Therapeutic Strategies

The book commences with a vivid and inspiring introduction contributed by Professor Michael Zasloff, a distinguished forerunner in the field. Part I provides an overview of nomenclature, classifi cation and bioinformatic analysis of antimicrobial peptides from bacteria, plants and animals. Sub...

Mô tả đầy đủ

Đã lưu trong:
Chi tiết về thư mục
Tác giả chính: Guangshun, Guangshun
Định dạng: Sách
Ngôn ngữ:English
Được phát hành: CABI 2014
Những chủ đề:
Truy cập trực tuyến:https://scholar.dlu.edu.vn/thuvienso/handle/DLU123456789/36979
Các nhãn: Thêm thẻ
Không có thẻ, Là người đầu tiên thẻ bản ghi này!
Thư viện lưu trữ: Thư viện Trường Đại học Đà Lạt
id oai:scholar.dlu.edu.vn:DLU123456789-36979
record_format dspace
spelling oai:scholar.dlu.edu.vn:DLU123456789-369792023-11-11T05:27:20Z Antimicrobial Peptides Discovery, Design and Novel Therapeutic Strategies Guangshun, Guangshun Antimicrobial Therapeutic The book commences with a vivid and inspiring introduction contributed by Professor Michael Zasloff, a distinguished forerunner in the field. Part I provides an overview of nomenclature, classifi cation and bioinformatic analysis of antimicrobial peptides from bacteria, plants and animals. Subsequently, lantibiotics from bacteria and cyclotides from plants are presented. These unique peptide templates with multiple sulfur-mediated bridges are resistant to proteases, rendering them attractive for engineering new compounds for food preservation, pest control and curing diseases. Part II discusses database-aided peptide prediction and design methods, synthetic combinatorial libraries and peptide mimetics that expand the conformational space of natural antimicrobial peptides. These approaches also allow for the optimization of the desired properties and therapeutic index of the peptide analogues or mimicries. An in-depth understanding of the mode of action of these peptides is essential for drug development. As a consequence, Part III covers the biophysical and structural characterization of antimicrobial peptides and their complexes. While many peptides (e.g. magainin and protegrin-1) target bacterial membranes, apidaecin, buforin II, PR-39 and others can cross bacterial membranes and associate with internal targets such as heat-shock proteins and nucleic acids. Structural determination sheds light on how such peptides recognize membrane or non-membrane targets at atomic resolution, and provides the basis for structurebased peptide design. Finally, Part IV focuses on novel strategies for developing peptide-based therapies. These include liberating LL-37 from the inactive bound state in infected lungs, enhancing the expression of human cathelicidin and human β-defensin-2 by vitamin D, and stimulating immune responses to bacterial invasion by applying peptide analogues that may or may not kill bacteria directly. 2014-04-17T08:38:01Z 2014-04-17T08:38:01Z 2010 Book 978 1 84593 657 0 https://scholar.dlu.edu.vn/thuvienso/handle/DLU123456789/36979 en application/pdf CABI
institution Thư viện Trường Đại học Đà Lạt
collection Thư viện số
language English
topic Antimicrobial
Therapeutic
spellingShingle Antimicrobial
Therapeutic
Guangshun, Guangshun
Antimicrobial Peptides Discovery, Design and Novel Therapeutic Strategies
description The book commences with a vivid and inspiring introduction contributed by Professor Michael Zasloff, a distinguished forerunner in the field. Part I provides an overview of nomenclature, classifi cation and bioinformatic analysis of antimicrobial peptides from bacteria, plants and animals. Subsequently, lantibiotics from bacteria and cyclotides from plants are presented. These unique peptide templates with multiple sulfur-mediated bridges are resistant to proteases, rendering them attractive for engineering new compounds for food preservation, pest control and curing diseases. Part II discusses database-aided peptide prediction and design methods, synthetic combinatorial libraries and peptide mimetics that expand the conformational space of natural antimicrobial peptides. These approaches also allow for the optimization of the desired properties and therapeutic index of the peptide analogues or mimicries. An in-depth understanding of the mode of action of these peptides is essential for drug development. As a consequence, Part III covers the biophysical and structural characterization of antimicrobial peptides and their complexes. While many peptides (e.g. magainin and protegrin-1) target bacterial membranes, apidaecin, buforin II, PR-39 and others can cross bacterial membranes and associate with internal targets such as heat-shock proteins and nucleic acids. Structural determination sheds light on how such peptides recognize membrane or non-membrane targets at atomic resolution, and provides the basis for structurebased peptide design. Finally, Part IV focuses on novel strategies for developing peptide-based therapies. These include liberating LL-37 from the inactive bound state in infected lungs, enhancing the expression of human cathelicidin and human β-defensin-2 by vitamin D, and stimulating immune responses to bacterial invasion by applying peptide analogues that may or may not kill bacteria directly.
format Book
author Guangshun, Guangshun
author_facet Guangshun, Guangshun
author_sort Guangshun, Guangshun
title Antimicrobial Peptides Discovery, Design and Novel Therapeutic Strategies
title_short Antimicrobial Peptides Discovery, Design and Novel Therapeutic Strategies
title_full Antimicrobial Peptides Discovery, Design and Novel Therapeutic Strategies
title_fullStr Antimicrobial Peptides Discovery, Design and Novel Therapeutic Strategies
title_full_unstemmed Antimicrobial Peptides Discovery, Design and Novel Therapeutic Strategies
title_sort antimicrobial peptides discovery, design and novel therapeutic strategies
publisher CABI
publishDate 2014
url https://scholar.dlu.edu.vn/thuvienso/handle/DLU123456789/36979
_version_ 1782541734557777920